ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BNTC Benitec Biopharma Limited

8.64
0.49 (6.01%)
08 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Benitec Biopharma Limited BNTC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.49 6.01% 8.64 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.03 8.03 8.7615 8.64 8.15
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/3/202415:17EDGAR2Form 8-K - Current report
08/3/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202408:06EDGAR2Form DEL AM - Delaying amendment
23/2/202415:09EDGAR2Form S-3 - Registration statement under Securities Act of..
13/2/202407:15EDGAR2Form 8-K - Current report
13/2/202407:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/12/202315:15EDGAR2Form 8-K - Current report
30/11/202306:31EDGAR2Form 8-K - Current report
17/11/202307:00GLOBEBenitec Biopharma to Participate in a Fireside Chat at the..
13/11/202307:03EDGAR2Form 8-K - Current report
13/11/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202307:00GLOBEBenitec Biopharma Releases First Quarter 2024 Financial..
20/10/202315:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/10/202305:04EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202316:29EDGAR2Form 8-K - Current report
28/9/202316:19EDGAR2Form 8-K - Current report
21/9/202307:05EDGAR2Form 8-K - Current report
21/9/202307:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/9/202307:00GLOBEBenitec Biopharma Releases Full Year 2023 Financial Results..
18/9/202316:26EDGAR2Form 8-K - Current report
14/8/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:01EDGAR2Form 8-K - Current report
11/8/202312:00GLOBEBenitec Biopharma Inc. Announces Closing of $30 Million..
10/8/202315:42EDGAR2Form 8-K - Current report
10/8/202315:06EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
08/8/202321:30GLOBEBenitec Biopharma Inc. Announces Pricing of $30 Million..
07/8/202307:11EDGAR2Form S-1/A - General form for registration of securities..
03/8/202307:27EDGAR2Form S-1/A - General form for registration of securities..
31/7/202307:34EDGAR2Form S-1/A - General form for registration of securities..
25/7/202313:08EDGAR2Form 8-K - Current report
25/7/202312:00GLOBEBenitec Biopharma Announces 1-for-17 Reverse Stock Split..
07/7/202315:52EDGAR2Form S-1 - General form for registration of securities under..
26/6/202307:00GLOBEBenitec Biopharma Receives FDA Clearance of the IND for..
15/5/202307:00GLOBEBenitec Biopharma Releases Third Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock